Atom Bioworks
PrivateLast Round
Grant
Sep 7, 2022
Total Funding Raised
$4.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Atom Bioworks is a biotechnology company that develops a platform for programming DNA and RNA-based biomolecules as high-affinity binding reagents for applications in drug delivery and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Low-Code/No-Code
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atom Bioworks Comparables
Compare Atom Bioworks with similar companies based on industry and business-model similarity.
Atom Bioworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 7, 2022 | ||||
| Grant | Aug 1, 2022 | ||||
| Seed | Jan 1, 2021 | ||||
| Grant | Jun 1, 2020 |
Atom Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Dental and Craniofacial Research | Grant, Seed |
| Y Combinator | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 116% MoM.
- Sep 7, 2022
$450K awarded by National Institute of Dental and Craniofacial Research
Atom Bioworks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access